Dystrogen Therapeutics


Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company is currently testing DEC therapy for Duchenne Muscular Dystrophy.

Industries

Employees

1-10

Links


Org chart

Kris Siemionow
Co-Founder & CEO
Collapse
Maria Siemionow
Founder & CSO

Board & advisors

Paul Lewicki
Co-Founder & Board Member


Offices